Bulin Du

479 total citations
36 papers, 369 citations indexed

About

Bulin Du is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bulin Du has authored 36 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 13 papers in Cancer Research and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bulin Du's work include Lung Cancer Treatments and Mutations (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and RNA modifications and cancer (5 papers). Bulin Du is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and RNA modifications and cancer (5 papers). Bulin Du collaborates with scholars based in China, United States and Russia. Bulin Du's co-authors include Xuena Li, Yaming Li, Chunrong Qu, Kun Qian, Zhen Cheng, Ruiqi Liu, Meng Xia, Yan Cui, Yan Cui and Yesen Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Biochemical Pharmacology.

In The Last Decade

Bulin Du

32 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bulin Du China 12 174 117 95 91 64 36 369
Dain Kim South Korea 7 203 1.2× 126 1.1× 71 0.7× 66 0.7× 57 0.9× 18 391
Sung Ouk Nam Japan 10 130 0.7× 96 0.8× 79 0.8× 82 0.9× 61 1.0× 15 315
Olav Engebråten Norway 11 186 1.1× 87 0.7× 109 1.1× 100 1.1× 83 1.3× 18 417
Zhiying Shao China 12 174 1.0× 69 0.6× 117 1.2× 117 1.3× 95 1.5× 38 493
Mihaela Popa Norway 13 195 1.1× 107 0.9× 186 2.0× 41 0.5× 123 1.9× 25 507
Jade Mims United States 7 176 1.0× 133 1.1× 77 0.8× 46 0.5× 50 0.8× 7 356
Xiaoxiang Fan China 11 167 1.0× 62 0.5× 46 0.5× 35 0.4× 75 1.2× 32 377
Zhaoze Guo China 12 223 1.3× 127 1.1× 136 1.4× 72 0.8× 148 2.3× 28 497

Countries citing papers authored by Bulin Du

Since Specialization
Citations

This map shows the geographic impact of Bulin Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bulin Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bulin Du more than expected).

Fields of papers citing papers by Bulin Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bulin Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bulin Du. The network helps show where Bulin Du may publish in the future.

Co-authorship network of co-authors of Bulin Du

This figure shows the co-authorship network connecting the top 25 collaborators of Bulin Du. A scholar is included among the top collaborators of Bulin Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bulin Du. Bulin Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Yuxiang, Yan Cui, Bulin Du, Xuena Li, & Yaming Li. (2025). Skull Base Metastasis of Uterine Carcinosarcoma Mimicking Primary Carcinoma of the Middle Ear. Clinical Nuclear Medicine. 50(5). 419–420.
3.
Du, Bulin, et al.. (2024). HMGA1 is a Prognostic Biomarker and Correlated with Glycolysis in Lung Adenocarcinoma. Journal of Cancer. 15(10). 2913–2927. 4 indexed citations
4.
Liu, Guang‐Hui, et al.. (2024). Additional Findings of 18F-AIF-FAPI-42 PET/CT in a Patient With Mycosis Fungoides–Type Cutaneous T-Cell Lymphoma. Clinical Nuclear Medicine. 49(5). e199–e201. 1 indexed citations
5.
Zhang, Jiani, Bulin Du, Yuxiang Wang, et al.. (2024). The role of CD8 PET imaging in guiding cancer immunotherapy. Frontiers in Immunology. 15. 1428541–1428541. 5 indexed citations
6.
Cui, Yan, et al.. (2023). PTPRH promotes the progression of non-small cell lung cancer via glycolysis mediated by the PI3K/AKT/mTOR signaling pathway. Journal of Translational Medicine. 21(1). 819–819. 25 indexed citations
7.
Du, Bulin, Yan Cui, Guang‐Hui Liu, Yaming Li, & Xuena Li. (2023). Multimodality imaging of a rare synchronous double primary cardiac leiomyosarcoma. European Heart Journal - Cardiovascular Imaging. 24(12). e303–e303. 2 indexed citations
8.
9.
Du, Bulin, Shu Wang, Yi Liu, Yaming Li, & Xuena Li. (2022). Metastatic Papillary Thyroid Cancer Mimicking Hypopharyngeal Carcinoma. Clinical Nuclear Medicine. 48(1). 90–91. 2 indexed citations
10.
11.
Chen, Meijie, Xuena Li, Bulin Du, Song Chen, & Yaming Li. (2022). Upstream stimulatory factor 2 inhibits erastin-induced ferroptosis in pancreatic cancer through transcriptional regulation of pyruvate kinase M2. Biochemical Pharmacology. 205. 115255–115255. 15 indexed citations
12.
Du, Bulin, Ruiqi Liu, Chunrong Qu, et al.. (2022). J-aggregates albumin-based NIR-II fluorescent dye nanoparticles for cancer phototheranostics. Materials Today Bio. 16. 100366–100366. 31 indexed citations
13.
X, Li, et al.. (2020). PD-L1 in Lung Adenocarcinoma: Insights into the Role of 18F-FDG PET/CT. SHILAP Revista de lepidopterología. 1 indexed citations
14.
Xia, Meng, et al.. (2020). Targeted inhibition of glutamine metabolism enhances the antitumor effect of selumetinib in KRAS-mutant NSCLC. Translational Oncology. 14(1). 100920–100920. 34 indexed citations
15.
Du, Bulin, Chunrong Qu, Kun Qian, et al.. (2019). An IR820 Dye–Protein Complex for Second Near‐Infrared Window and Photoacoustic Imaging. Advanced Optical Materials. 8(4). 59 indexed citations
16.
Li, Xuena, et al.. (2019). MicroRNA-4458 suppresses migration and epithelial–mesenchymal transition via targeting HMGA1 in non-small-cell lung cancer cells. Cancer Management and Research. Volume 11. 637–649. 23 indexed citations
17.
18.
Du, Bulin, Xuena Li, Na Li, Yaming Li, & Bailing Hsu. (2014). 18F-FDG Hepatic Superscan in a Patient With Chronic Myeloid Leukemia. Clinical Nuclear Medicine. 39(9). 835–836. 16 indexed citations
19.
20.
Li, Guiling, et al.. (1996). [The relationship of non-Hodgkin's lymphoma with P16 protein expression].. PubMed. 27(3). 254–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dain Kim Breakdown of academic impact, for papers by Sung Ouk Nam Breakdown of academic impact, for papers by Olav Engebråten Breakdown of academic impact, for papers by Zhiying Shao Breakdown of academic impact, for papers by Mihaela Popa Breakdown of academic impact, for papers by Jade Mims Breakdown of academic impact, for papers by Xiaoxiang Fan Breakdown of academic impact, for papers by Zhaoze Guo
Rankless by CCL
2026